Early test puts new Humira-Like drug under the microscope
NCT ID NCT07181694
Summary
This early-stage study aims to see how two different concentrations of a new biosimilar drug called BCD-057 compare to the existing drug Humira in healthy men. Researchers will give a single injection to 444 healthy male volunteers and closely track how the drug moves through and leaves their bodies over 71 days. The main goal is to gather data on drug levels, safety, and immune responses to see if BCD-057 behaves similarly to Humira.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
I.M. Sechenov First Moscow State Medical University
RECRUITINGMoscow, 119435, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LLC "Research Center Eco-Safety"
RECRUITINGSaint Petersburg, 196143, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LLC "X7 Clinical Research"
RECRUITINGSaint Petersburg, 194156, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LLC "X7 Clinical Research"
RECRUITINGSaint Petersburg, 199178, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.